SIMDAX 2.5mg / ml perfusive solution concentrate medication leaflet

C01CX08 levosimendan • Cardiovascular system | Cardiac stimulants excluding cardiac glycosides | Other cardiac stimulants

Levosimendan is a medication used for the treatment of acute decompensated heart failure. It acts as a calcium sensitizer, improving myocardial contractility without increasing oxygen consumption.

The medication is administered intravenously, usually as an infusion, under the supervision of a specialist. The dose is adjusted based on the patient's response and tolerance.

Side effects may include low blood pressure, headaches, nausea, or cardiac arrhythmias. In rare cases, severe allergic reactions may occur.

Levosimendan is not recommended for patients with severe hypotension, severe renal or hepatic impairment, or hypersensitivity to this medication.

General data about SIMDAX 2.5mg / ml

Substance: levosimendan

Date of last drug list: 01-05-2024

Commercial code: W68192001

Concentration: 2.5mg / ml

Pharmaceutical form: perfusive solution concentrate

Packing volume: 5ml

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ORION CORPORATION - FINLANDA

Holder: ALLIANCE HEALTHCARE ROMÂNIA SRL - ROMANIA

Number: 667/2021/01

Shelf life: 2 years

Other substances similar to levosimendan